These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of voglibose on glycemic excursions, insulin secretion, and insulin sensitivity in non-insulin-treated NIDDM patients. Matsumoto K, Yano M, Miyake S, Ueki Y, Yamaguchi Y, Akazawa S, Tominaga Y. Diabetes Care; 1998 Feb; 21(2):256-60. PubMed ID: 9539992 [Abstract] [Full Text] [Related]
3. Effects of changeover from voglibose to acarbose on postprandial triglycerides in type 2 diabetes mellitus patients. Matsumura M, Monden T, Miyashita Y, Kawagoe Y, Shimizu H, Nakatani Y, Domeki N, Yanagi K, Ikeda S, Kasai K. Adv Ther; 2009 Jun; 26(6):660-6. PubMed ID: 19568704 [Abstract] [Full Text] [Related]
4. Beneficial effect of long-term combined treatment with voglibose and pioglitazone on pancreatic islet function of genetically diabetic GK rats. Ishida H, Kato S, Nishimura M, Mizuno N, Fujimoto S, Mukai E, Kajikawa M, Yamada Y, Odaka H, Ikeda H, Seino Y. Horm Metab Res; 1998 Nov; 30(11):673-8. PubMed ID: 9918384 [Abstract] [Full Text] [Related]
5. The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients. Flint A, Kapitza C, Hindsberger C, Zdravkovic M. Adv Ther; 2011 Mar; 28(3):213-26. PubMed ID: 21340616 [Abstract] [Full Text] [Related]
6. Rate of gastric emptying is a determinant of postprandial hypotension in non-insulin-dependent diabetes mellitus. Jones KL, Tonkin A, Horowitz M, Wishart JM, Carney BI, Guha S, Green L. Clin Sci (Lond); 1998 Jan; 94(1):65-70. PubMed ID: 9505868 [Abstract] [Full Text] [Related]
9. Effect of an alpha-glucosidase inhibitor (voglibose), in combination with sulphonylureas, on glycaemic control in type 2 diabetes patients. Saito N, Sakai H, Suzuki S, Sekihara H, Yajima Y. J Int Med Res; 1998 Jan; 26(5):219-32. PubMed ID: 9924706 [Abstract] [Full Text] [Related]
10. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients. Hücking K, Kostic Z, Pox C, Ritzel R, Holst JJ, Schmiegel W, Nauck MA. Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675 [Abstract] [Full Text] [Related]
12. Comparison of efficacies of a dipeptidyl peptidase IV inhibitor and alpha-glucosidase inhibitors in oral carbohydrate and meal tolerance tests and the effects of their combination in mice. Yamazaki K, Inoue T, Yasuda N, Sato Y, Nagakura T, Takenaka O, Clark R, Saeki T, Tanaka I. J Pharmacol Sci; 2007 May; 104(1):29-38. PubMed ID: 17485917 [Abstract] [Full Text] [Related]
19. The impact of soluble dietary fibre on gastric emptying, postprandial blood glucose and insulin in patients with type 2 diabetes. Yu K, Ke MY, Li WH, Zhang SQ, Fang XC. Asia Pac J Clin Nutr; 2014 Jul; 23(2):210-8. PubMed ID: 24901089 [Abstract] [Full Text] [Related]